申请人:BASF Aktiengesellschaft
公开号:US05330995A1
公开(公告)日:1994-07-19
The use of nicotinic anilide derivatives of the general formula ##STR1## where the substituents have the following meanings: R.sup.1 halogen, methyl, trifluoromethyl, methoxy, methylthio, methylsulfinyl, methylsulfonyl R.sup.2 unsubstituted or halogen-substituted alkyl, unsubsituted or halogen-substituted alkenyl, alkynyl, unsubstituted or halogen-substituted alkoxy, unsubstituted or halogen-substituted alkenyloxy, alkynyloxy, cycloalkyl, cycloalkenyl, cycloalkyloxy, cycloalkenloxy for combating Botrytis, and nicotinic anilides of the formula I.
通用公式##STR1##中使用烟酰苯胺衍生物,其中取代基具有以下含义:R.sup.1卤素,甲基,三氟甲基,甲氧基,甲硫基,甲砜基,甲砜基R.sup.2未取代或卤素取代的烷基,未取代或卤素取代的烯基,炔基,未取代或卤素取代的烷氧基,未取代或卤素取代的烯氧基,炔氧基,环烷基,环烯基,环烷氧基,环烯氧基,用于对抗灰霉病的烟酰苯胺和公式I的烟酰苯胺。